CF (gCO2e) value of specific MDI products, containing HFA134a propellant, CF estimation of the same products if formulated with a low GWP propellant (HFA152a)1 and CF of specific DPI products
| Product name (INN) | Strength (µg/actuation) | Type of device | Actuations per inhaler | CF (gCO2e/actuation) | |
| With HFA134a (certified) | With HFA152a6 (estimated) | ||||
| Clenil (beclometasone dipropionate) | 100 | MDI | 200 | 83.10 | 9.39 |
| Clenil (beclometasone dipropionate) | 200 | MDI | 200 | 81.96 | 9.31 |
| Foster (beclometasone dipropionate/formoterol) | 100/6 | MDI | 120 | 94.42 | 12.10 |
| Foster (beclometasone dipropionate/formoterol) | 200/6 | MDI | 120 | 118.56 | 14.05 |
| Foster NEXThaler (beclometasone dipropionate/formoterol) | 100/6 | DPI | 120 | 7.63 | Not applicable |
| Foster NEXThaler (beclometasone dipropionate/formoterol) | 200/6 | DPI | 120 | 7.64 | Not applicable |
| Trimbow (beclometasone dipropionate/formoterol/glycopyrronium) | 87/5/9* | MDI | 120 | 118.99 | 14.34 |
HFA134a, 1,1,1,2-tetrafluoroethane (GWP value 13001); HFA152a 1,1-difluoroethane (GWP value 1381).
*Delivered dose.
CF, carbon footprint; DPI, dry powder inhaler; GWP, global warming potential; HFA, hydrofluoroalkane; INN, International Nonproprietary Names ; MDI, metered dose inhaler.